Multiple TP53 p.R337H haplotypes and implications for tumor susceptibility.

Pinto EM, Fridman C, Figueiredo BC, Salvador H, Teixeira MR, Pinto C, Pinheiro M, Kratz CP, Lavarino C, Legal EAMF, Le A, Kelly G, Koeppe E, Stoffel EM, Breen K, Hahner S, Heinze B, Techavichit P, Krause A, Ogata T, Fujisawa Y, Walsh MF, Rana HQ, Maxwell KN, Garber JE, Rodriguez-Galindo C, Ribeiro RC, Zambetti GP

Open source

DOI: 10.1016/j.xhgg.2023.100244
Published: 2024 Jan 11
Container: HGG advances
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.xhgg.2023.100244,
  title = {Multiple TP53 p.R337H haplotypes and implications for tumor susceptibility.},
  author = {Pinto EM and Fridman C and Figueiredo BC and Salvador H and Teixeira MR and Pinto C and Pinheiro M and Kratz CP and Lavarino C and Legal EAMF and Le A and Kelly G and Koeppe E and Stoffel EM and Breen K and Hahner S and Heinze B and Techavichit P and Krause A and Ogata T and Fujisawa Y and Walsh MF and Rana HQ and Maxwell KN and Garber JE and Rodriguez-Galindo C and Ribeiro RC and Zambetti GP},
  year = {2024},
  journal = {HGG advances},
  doi = {10.1016/j.xhgg.2023.100244},
  url = {https://doi.org/10.1016/j.xhgg.2023.100244}
}

RIS

TY  - JOUR
TI  - Multiple TP53 p.R337H haplotypes and implications for tumor susceptibility.
AU  - Pinto EM
AU  - Fridman C
AU  - Figueiredo BC
AU  - Salvador H
AU  - Teixeira MR
AU  - Pinto C
AU  - Pinheiro M
AU  - Kratz CP
AU  - Lavarino C
AU  - Legal EAMF
AU  - Le A
AU  - Kelly G
AU  - Koeppe E
AU  - Stoffel EM
AU  - Breen K
AU  - Hahner S
AU  - Heinze B
AU  - Techavichit P
AU  - Krause A
AU  - Ogata T
AU  - Fujisawa Y
AU  - Walsh MF
AU  - Rana HQ
AU  - Maxwell KN
AU  - Garber JE
AU  - Rodriguez-Galindo C
AU  - Ribeiro RC
AU  - Zambetti GP
PY  - 2024
JO  - HGG advances
DO  - 10.1016/j.xhgg.2023.100244
UR  - https://doi.org/10.1016/j.xhgg.2023.100244
ER  -

APA

EM, P., C, F., BC, F., H, S., MR, T., C, P., M, P., CP, K., C, L., EAMF, L., A, L., G, K., E, K., EM, S., K, B., S, H., B, H., P, T., A, K., T, O., Y, F., MF, W., HQ, R., KN, M., JE, G., C, R., RC, R., & GP, Z. (2024). Multiple TP53 p.R337H haplotypes and implications for tumor susceptibility.. HGG advances. https://doi.org/10.1016/j.xhgg.2023.100244

Source records

pubmed · retrieved 2026-09-26T07:11:17.916Z